STI571: a magic bullet?

[1] ABELSON HT, 1970, CANCER RES, V30, P2213

[2] Blanke CD, 2001, P AM SOC CLIN ONCOL, p1a

[3] Buchdunger E, 1996, CANCER RES, V56, P100

[4] Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139

[5] CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [J]. BLOOD, 1997, 90 (12) : 4947 - 4952

[6] DEISSEROTH AB, 1994, CANC PRINCIPLES PRAC, P1965

[7] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1038 - 1042

[8] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037

[9] Gastrointestinal stromal tumors: Their origin and cause [J]. International Journal of Clinical Oncology, 2001, 6 (1) : 1 - 5

[10] Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1052 - 1056

[1] ABELSON HT, 1970, CANCER RES, V30, P2213

[2] Blanke CD, 2001, P AM SOC CLIN ONCOL, p1a

[3] Buchdunger E, 1996, CANCER RES, V56, P100

[4] Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139

[5] CGP 57148, a tyrosine kinase inhibitor, inhibits the growth of cells expressing BCR-ABL, TEL-ABL, and TEL-PDGFR fusion proteins [J]. BLOOD, 1997, 90 (12) : 4947 - 4952

[6] DEISSEROTH AB, 1994, CANC PRINCIPLES PRAC, P1965

[7] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1038 - 1042

[8] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1031 - 1037

[9] Gastrointestinal stromal tumors: Their origin and cause [J]. International Journal of Clinical Oncology, 2001, 6 (1) : 1 - 5

[10] Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) : 1052 - 1056